KIR2DL1 and neoplasm: It has been found that in tumor cells, immune checkpoints can lead to NK cell dysfunction, blocking these immune checkpoints (e.g. TIM-3, NKG2A, CTLA-4, PD-1, KIR2DL-1/2/3, CD96, TIGIT) can restore the function of NK cells (186).